ZMYM4

Summary

ZMYM4 (zinc finger MYM-type containing 4, HGNC:13055) is a protein-coding gene on chromosome 1p34.3, encoding Zinc finger MYM-type protein 4 (Q5VZL5). Plays a role in the regulation of cell morphology and cytoskeletal organization.

Predicted to enable DNA binding activity. Involved in cytoskeleton organization and regulation of cell morphogenesis.

Source: NCBI Gene 9202 — RefSeq curated summary.

At a glance

• GWAS associations: 5
• Clinical variants (ClinVar): 158 total
• MANE Select transcript: NM_005095

Identifiers

Gene identifiers

Field	Value
HGNC ID	HGNC:13055
Approved symbol	ZMYM4
Name	zinc finger MYM-type containing 4
Location	1p34.3
Locus type	gene with protein product
Status	Approved
Aliases	KIAA0425, ZNF198L3, MYM
Ensembl gene	ENSG00000146463
Ensembl biotype	protein_coding
OMIM	613568
Entrez	9202

Gene structure

Transcript identifiers

Ensembl transcripts: 9 — 6 protein_coding, 3 protein_coding_CDS_not_defined

ENST00000314607, ENST00000441447, ENST00000457946, ENST00000470175, ENST00000482131, ENST00000492456, ENST00000933224, ENST00000933225, ENST00000933226

RefSeq mRNA: 5 — MANE Select: NM_005095 NM_001350138, NM_001350139, NM_001350140, NM_001375653, NM_005095

CCDS: CCDS389

Canonical transcript exons

ENST00000314607 — 30 exons

Exon	Start	End
ENSE00000955938	35418443	35418572
ENSE00001066906	35405023	35405194
ENSE00001066912	35385442	35385592
ENSE00001066914	35408008	35408159
ENSE00001066919	35387003	35387278
ENSE00001066928	35397377	35397545
ENSE00001066929	35381546	35381758
ENSE00001066931	35413972	35414083
ENSE00001066932	35389948	35390098
ENSE00001125229	35415466	35415714
ENSE00001125276	35399482	35399576
ENSE00001125285	35398864	35399043
ENSE00001125294	35398413	35398466
ENSE00001125330	35392647	35392684
ENSE00001125338	35392212	35392352
ENSE00001125352	35388910	35389082
ENSE00001125375	35386074	35386189
ENSE00001125401	35381259	35381433
ENSE00001417767	35361619	35361789
ENSE00001425567	35361194	35361255
ENSE00001429123	35370372	35370627
ENSE00001616388	35387454	35387604
ENSE00001626559	35419470	35422058
ENSE00001670766	35268709	35269085
ENSE00001765619	35358925	35359446
ENSE00003474598	35393595	35393739
ENSE00003478009	35370029	35370113
ENSE00003482654	35396552	35396670
ENSE00003615141	35325360	35325405
ENSE00003688215	35405373	35405468

Expression profiles

Bgee: expression breadth ubiquitous, 299 present calls, max score 96.56.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 20.4391 / max 204.9543, expressed in 1806 samples.

FANTOM5 promoters (12 alternative TSS)

Promoter ID	TPM avg	Samples expressed
2087	9.5358	1766
2090	3.0914	1341
2088	2.6797	1356
2094	1.1860	792
2089	0.8762	581
2097	0.8235	512
2096	0.6809	421
2100	0.4908	214
2093	0.3057	128
2095	0.2778	118

Top tissues by expression

302 total, by Bgee expression score (0-100, higher = more expressed):

Tissue	Anatomy ID	Expression score	Quality
calcaneal tendon	UBERON:0003701	96.56	gold quality
ventricular zone	UBERON:0003053	95.72	gold quality
cortical plate	UBERON:0005343	93.99	gold quality
ganglionic eminence	UBERON:0004023	93.69	gold quality
choroid plexus epithelium	UBERON:0003911	93.34	gold quality
cerebellar vermis	UBERON:0004720	93.09	gold quality
embryo	UBERON:0000922	92.90	gold quality
colonic epithelium	UBERON:0000397	92.89	gold quality
adrenal tissue	UBERON:0018303	92.65	gold quality
Brodmann (1909) area 23	UBERON:0013554	92.37	gold quality
buccal mucosa cell	CL:0002336	92.24	gold quality
cauda epididymis	UBERON:0004360	92.00	gold quality
orbitofrontal cortex	UBERON:0004167	91.98	gold quality
sperm	CL:0000019	91.88	gold quality
caput epididymis	UBERON:0004358	91.73	gold quality
pigmented layer of retina	UBERON:0001782	91.71	gold quality
male germ cell	CL:0000015	91.57	gold quality
germinal epithelium of ovary	UBERON:0001304	91.39	gold quality
middle temporal gyrus	UBERON:0002771	91.30	gold quality
epithelial cell of pancreas	CL:0000083	91.17	gold quality
Brodmann (1909) area 46	UBERON:0006483	91.12	gold quality
diaphragm	UBERON:0001103	90.93	silver quality
oviduct epithelium	UBERON:0004804	90.91	gold quality
lateral nuclear group of thalamus	UBERON:0002736	90.58	gold quality
parietal pleura	UBERON:0002400	90.38	gold quality
cardiac muscle of right atrium	UBERON:0003379	90.38	gold quality
skeletal muscle tissue of biceps brachii	UBERON:0004502	90.17	gold quality
corpus epididymis	UBERON:0004359	90.06	gold quality
pons	UBERON:0000988	90.03	gold quality
biceps brachii	UBERON:0001507	90.02	gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

Experiment	Marker?	Max mean expression
E-ANND-3	yes	7.50

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

173 targeting ZMYM4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNA	Max score	Avg score	miRNA target_count
HSA-LET-7A-3P	100.00	74.03	3932
HSA-LET-7B-3P	100.00	74.08	3913
HSA-LET-7F-1-3P	100.00	74.02	3928
HSA-MIR-98-3P	100.00	74.08	3907
HSA-MIR-450A-1-3P	100.00	69.33	1837
HSA-MIR-3646	100.00	73.56	5283
HSA-MIR-6740-5P	100.00	65.64	932
HSA-MIR-4510	100.00	66.60	2050
HSA-MIR-513A-5P	100.00	69.77	2465
HSA-MIR-6127	100.00	66.76	2188
HSA-MIR-6129	100.00	66.46	2080
HSA-MIR-6130	100.00	66.69	2012
HSA-MIR-6133	100.00	66.48	2064
HSA-MIR-4476	100.00	68.18	2030
HSA-MIR-6876-5P	100.00	67.68	2126
HSA-MIR-200B-3P	100.00	73.31	2693
HSA-MIR-200C-3P	100.00	73.35	2685
HSA-MIR-429	100.00	73.44	2698
HSA-MIR-34A-5P	99.99	71.21	1784
HSA-MIR-449A	99.99	71.05	1776
HSA-MIR-4282	99.99	75.36	6408
HSA-MIR-3662	99.99	73.82	5684
HSA-MIR-150-5P	99.99	66.69	1976
HSA-MIR-27A-3P	99.98	72.13	2955
HSA-MIR-27B-3P	99.98	72.13	2955
HSA-MIR-9985	99.98	72.11	2939
HSA-MIR-485-3P	99.98	70.68	1585
HSA-MIR-539-3P	99.98	70.74	1616
HSA-LET-7F-2-3P	99.98	70.98	2588
HSA-MIR-1185-1-3P	99.98	71.04	2593

Literature-anchored findings (GeneRIF, showing 3)

• regulates apoptosis by altering mRNA turnover and CDIR inhibits apoptosis by acting as a competitive inhibitor of AUF1, preventing AUF1 from binding to its targets (PMID:12356764)
• Characterization of the zinc finger proteins ZMYM2 and ZMYM4 as novel B-MYB binding proteins. (PMID:32439918)
• Expression and Mutation Alterations of ZMYM4 Gene in Gastric and Colonic Cancers. (PMID:33938481)

Cross-species orthologs

2 orthologs

Organism	Symbol	Gene ID
mus_musculus	Zmym4	ENSMUSG00000042446
rattus_norvegicus	Zmym4	ENSRNOG00000012397

Paralogs (18): GTF2IRD1 (ENSG00000006704), ZMYM2 (ENSG00000121741), ZMYM5 (ENSG00000132950), THAP12 (ENSG00000137492), ZMYM3 (ENSG00000147130), ZMYM6 (ENSG00000163867), KIAA1958 (ENSG00000165185), GTF2IRD2B (ENSG00000174428), EPM2AIP1 (ENSG00000178567), GTF2IRD2 (ENSG00000196275), ZMYM1 (ENSG00000197056), QRICH1 (ENSG00000198218), FAM200C (ENSG00000221886), FAM200A (ENSG00000221909), SCAND3 (ENSG00000232040), ZBED5 (ENSG00000236287), FAM200B (ENSG00000237765), GTF2I (ENSG00000263001)

Protein

Protein identifiers

Zinc finger MYM-type protein 4 — Q5VZL5 (reviewed: Q5VZL5)

Alternative names: Zinc finger protein 262

All UniProt accessions (3): Q5VZL5, A0A0A0MSN3, H7C1I7

UniProt curated annotations — full annotation on UniProt →

Function. Plays a role in the regulation of cell morphology and cytoskeletal organization.

Tissue specificity. Expressed at higher level in heart, skeletal muscle, kidney and liver.

Miscellaneous. The 3’-UTR region of the mRNA encoding this protein contains a motif called CDIR (for cell death inhibiting RNA) that binds HNRPD/AUF1 and HSPB1/HSP27. It is able to inhibit interferon-gamma induced apoptosis.

Isoforms (4)

UniProt ID	Names	Canonical?
Q5VZL5-1	1	yes
Q5VZL5-2	2
Q5VZL5-3	3
Q5VZL5-4	4

RefSeq proteins (5): NP_001337067, NP_001337068, NP_001337069, NP_001362582, NP_005086* (*=MANE)

Domains & families (InterPro)

ID	Name	Type
IPR010507	Znf_MYM	Domain
IPR011017	TRASH_dom	Domain
IPR021893	ZMYM2-like_C	Domain
IPR051284	ZnF_MYMT-QRICH1	Family
IPR057926	QRICH1_dom	Domain

Pfam: PF06467, PF12012, PF24900, PF25561

UniProt features (58 total): cross-link 20, modified residue 15, zinc finger region 9, region of interest 3, compositionally biased region 3, splice variant 3, sequence variant 2, initiator methionine 1, chain 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

Model	pLDDT	Fraction very-high
AF-Q5VZL5-F1	59.70	0.21

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (35): 2, 107, 110, 122, 162, 197, 242, 1030, 1064, 1071, 1181, 1256, 1539, 1542, 1547, 140, 149, 195, 201, 232 …

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 180 (showing top): GOBP_REGULATION_OF_CELL_MORPHOGENESIS, TGCGCANK_UNKNOWN, GCANCTGNY_MYOD_Q6, MORF_HDAC2, CAGCTG_AP4_Q5, CATTTCA_MIR203, MYOD_01, MARTINEZ_RB1_TARGETS_DN, BLALOCK_ALZHEIMERS_DISEASE_UP, HEN1_01, chr1p34, DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN, GATA1_03, BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS, AACTTT_UNKNOWN

GO Biological Process (2): cytoskeleton organization (GO:0007010), regulation of cell morphogenesis (GO:0022604)

GO Molecular Function (4): DNA binding (GO:0003677), zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (0):

GO top-level categories

Rollup of top GO terms by namespace:

Category	Terms
organelle organization	1
cell morphogenesis	1
regulation of anatomical structure morphogenesis	1
nucleic acid binding	1
transition metal ion binding	1
binding	1
cation binding	1

Protein interactions and networks

STRING

1950 interactions, top by confidence (×1000):

Protein A	Protein B	Partner UniProt	Score
ZMYM4	RCOR1	Q9UKL0	633
ZMYM4	KDM1A	O60341	498
ZMYM4	UFSP2	Q9NUQ7	489
ZMYM4	FGFR1	P11362	471
ZMYM4	FKBP9	O95302	453
ZMYM4	TMEM35B	Q8NCS4	449
ZMYM4	SGSM3	Q96HU1	443
ZMYM4	CHMP7	Q8WUX9	433
ZMYM4	NUBPL	Q8TB37	431
ZMYM4	OTUD3	Q5T2D3	431
ZMYM4	DTYMK	P23919	420
ZMYM4	RNASEH2B	Q5TBB1	417
ZMYM4	ATF7IP	Q6VMQ6	412
ZMYM4	SUMO2	P55855	394
ZMYM4	HDAC1	Q13547	391
ZMYM4	DENND5B	Q6ZUT9	391

IntAct

190 interactions, top by confidence:

A	B	Type	Score
CDK8	MED19	psi-mi:“MI:2364”(proximity)	0.850
ZSCAN21	ZNF24	psi-mi:“MI:0914”(association)	0.830
DYNLL1	BLTP3B	psi-mi:“MI:0914”(association)	0.730
RHOC	RAP1GDS1	psi-mi:“MI:0914”(association)	0.730
CFTR	ESYT2	psi-mi:“MI:2364”(proximity)	0.710
NFIC	NFIB	psi-mi:“MI:2364”(proximity)	0.690
DYNLL2	BLTP3B	psi-mi:“MI:0914”(association)	0.640
QPRT	PIK3C2A	psi-mi:“MI:0914”(association)	0.640
ZNF397	ZNF213	psi-mi:“MI:0914”(association)	0.640
ZMYM4	ROR2	psi-mi:“MI:0915”(physical association)	0.560
ZMYM4	CTCF	psi-mi:“MI:0915”(physical association)	0.560
RUNX1T1	ZMYM4	psi-mi:“MI:0915”(physical association)	0.560
ZMYM4	FHL2	psi-mi:“MI:0915”(physical association)	0.560
UBQLN1	ZMYM4	psi-mi:“MI:0915”(physical association)	0.560
ZMYM4	UBQLN1	psi-mi:“MI:0915”(physical association)	0.560
ZMYM4	RUNX1T1	psi-mi:“MI:0915”(physical association)	0.560

BioGRID (224): ZMYM4 (Two-hybrid), ZMYM4 (Two-hybrid), ZMYM4 (Two-hybrid), CTCF (Two-hybrid), UBQLN1 (Two-hybrid), ZMYM4 (Affinity Capture-RNA), ZMYM4 (Affinity Capture-RNA), ZMYM4 (Protein-peptide), ZMYM4 (Affinity Capture-MS), ZMYM4 (Reconstituted Complex), ZMYM4 (Affinity Capture-MS), ZMYM4 (Affinity Capture-MS), ZMYM4 (Affinity Capture-MS), ZMYM4 (Co-fractionation), ZMYM4 (Co-fractionation)

ESM2 similar proteins: A0A1L8GR68, A2A791, B2GUN4, E1BP74, E1BZ85, F1QLG5, F7AQ22, O00472, O15164, O15550, O70546, O88974, O95789, P49140, P55265, P70365, Q14202, Q14596, Q15047, Q15788, Q4PJW2, Q5R413, Q5RC94, Q5RDJ2, Q5VZL5, Q64127, Q69Z66, Q6H8Q1, Q6KC51, Q6NXK2, Q6P3Y5, Q6PFK1, Q7Z3K3, Q8BJ34, Q8BL65, Q8BZH4, Q8CHY6, Q8IZD4, Q8TEW8, Q8VIG2

Diamond homologs: A2A791, A6QPH9, O95789, Q0P5J0, Q14202, Q2TAL8, Q3U2E2, Q3UA37, Q4R3D6, Q5RDJ2, Q5SVZ6, Q5VZL5, Q9CU65, Q9JLM4, Q9UBW7, Q9UJ78, A4Z943, A4Z944, A4Z945, P0CF97, Q49AG3, Q4R6P1, Q6R2W3, Q8IZ13, Q8TCP9

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 232 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

Pathway	Partners	Fold	FDR
Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	5	17.4×	6e-04
Transport of connexons to the plasma membrane	5	17.4×	6e-04
Formation of tubulin folding intermediates by CCT/TriC	6	16.3×	3e-04
Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding	6	15.7×	3e-04
Gap junction trafficking and regulation	5	15.2×	7e-04
Gap junction trafficking	5	15.2×	7e-04
Post-chaperonin tubulin folding pathway	5	15.2×	7e-04
Prefoldin mediated transfer of substrate to CCT/TriC	6	15.2×	3e-04

GO biological processes:

GO term	Partners	Fold	FDR
mRNA processing	12	4.5×	4e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

158 variants total. Per-class counts are floors (≥ shown; pagination cap):

Classification	Count (floor)
Pathogenic	0
Likely pathogenic	0
Uncertain significance	122
Likely benign	1
Benign	0

Top pathogenic / likely-pathogenic (0)

SpliceAI

5488 predictions. Top by Δscore:

Variant	Effect	Δscore
1:35269082:GAGG:G	donor_gain	1.0000
1:35269084:GG:G	donor_gain	1.0000
1:35269085:GG:G	donor_gain	1.0000
1:35269085:GGTA:G	donor_loss	1.0000
1:35269086:G:GG	donor_gain	1.0000
1:35269087:T:A	donor_loss	1.0000
1:35325358:A:AG	acceptor_gain	1.0000
1:35325359:G:GA	acceptor_gain	1.0000
1:35325359:GT:G	acceptor_gain	1.0000
1:35325359:GTTT:G	acceptor_gain	1.0000
1:35325401:GAACT:G	donor_gain	1.0000
1:35325402:AACT:A	donor_gain	1.0000
1:35325403:ACT:A	donor_gain	1.0000
1:35325404:CT:C	donor_gain	1.0000
1:35325406:G:GG	donor_gain	1.0000
1:35358922:AAGGT:A	acceptor_gain	1.0000
1:35359119:GATT:G	donor_gain	1.0000
1:35359173:G:GT	donor_gain	1.0000
1:35361254:GG:G	donor_gain	1.0000
1:35361255:GG:G	donor_gain	1.0000
1:35361614:TTTA:T	acceptor_loss	1.0000
1:35361616:TA:T	acceptor_loss	1.0000
1:35361617:A:AG	acceptor_gain	1.0000
1:35361617:A:C	acceptor_loss	1.0000
1:35361617:AG:A	acceptor_gain	1.0000
1:35361618:G:GG	acceptor_gain	1.0000
1:35361618:GG:G	acceptor_gain	1.0000
1:35361712:GATGA:G	donor_gain	1.0000
1:35361716:A:G	donor_gain	1.0000
1:35361748:GGAC:G	donor_gain	1.0000

AlphaMissense

10250 scored. Top likely-pathogenic:

Variant	Protein change	am_pathogenicity
1:35370078:T:A	I297N	1.000
1:35370078:T:C	I297T	1.000
1:35370078:T:G	I297S	1.000
1:35370087:T:A	V300E	1.000
1:35370089:T:C	F301L	1.000
1:35370091:T:A	F301L	1.000
1:35370091:T:G	F301L	1.000
1:35370467:T:A	C341S	1.000
1:35370467:T:C	C341R	1.000
1:35370467:T:G	C341G	1.000
1:35370468:G:A	C341Y	1.000
1:35370468:G:C	C341S	1.000
1:35370468:G:T	C341F	1.000
1:35370469:T:G	C341W	1.000
1:35370476:T:A	C344S	1.000
1:35370476:T:C	C344R	1.000
1:35370477:G:A	C344Y	1.000
1:35370477:G:C	C344S	1.000
1:35370477:G:T	C344F	1.000
1:35370478:T:G	C344W	1.000
1:35370489:T:A	L348H	1.000
1:35370489:T:C	L348P	1.000
1:35370497:G:A	G351R	1.000
1:35370497:G:C	G351R	1.000
1:35370498:G:A	G351E	1.000
1:35370501:A:C	Q352P	1.000
1:35370507:C:A	A354D	1.000
1:35370509:T:A	Y355N	1.000
1:35370509:T:C	Y355H	1.000
1:35370509:T:G	Y355D	1.000

dbSNP variants (sampled 300 via entrez): RS1000000642 (1:35269374 G>A), RS1000003586 (1:35417251 AAAAG>A,AAAAGAAAG), RS1000030174 (1:35388550 T>C), RS1000032644 (1:35282589 T>C), RS1000037998 (1:35410791 A>C,G), RS1000044025 (1:35379248 G>A), RS1000058138 (1:35372670 AT>A), RS1000069890 (1:35388181 A>C,G), RS1000100263 (1:35302552 A>G,T), RS1000104423 (1:35294489 G>A,C), RS1000107211 (1:35345484 C>T), RS1000139548 (1:35322131 A>G,T), RS1000162754 (1:35333054 C>T), RS1000172022 (1:35347715 G>A), RS1000175353 (1:35376497 G>A)

Disease associations

OMIM: gene MIM:613568 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

5 associations (top):

Study	Trait	p-value
GCST003542_28	Night sleep phenotypes	8.000000e-08
GCST005038_30	Allergic disease (asthma, hay fever or eczema)	1.000000e-08
GCST90002394_132	Monocyte percentage of white cells	2.000000e-13
GCST90020024_12	A body shape index	5.000000e-08
GCST90020029_1255	Waist circumference adjusted for body mass index	2.000000e-08

EFO canonical traits (2, from GWAS)

EFO ID	Trait name
EFO:0007989	monocyte percentage of leukocytes
EFO:0007789	BMI-adjusted waist circumference

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

29 total (human), top 29 by PubMed support.

Chemical	Actions (top 5)	PubMed papers
Valproic Acid	affects expression, decreases expression	4
aristolochic acid I	decreases expression	1
FR900359	affects phosphorylation	1
TAK-243	decreases sumoylation	1
triphenyl phosphate	affects expression	1
geraniol	increases expression	1
arsenite	affects binding, decreases reaction	1
benzo(e)pyrene	increases methylation	1
potassium chromate(VI)	decreases expression, affects cotreatment	1
aflatoxin B2	decreases methylation	1
epigallocatechin gallate	affects cotreatment, decreases expression	1
CGP 52608	affects binding, increases reaction	1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	affects cotreatment, increases expression	1
jinfukang	affects cotreatment, decreases expression	1
LDN 193189	affects cotreatment, increases expression	1
Acetaminophen	decreases expression	1
Air Pollutants	decreases expression, increases abundance	1
Atrazine	decreases expression	1
Caffeine	decreases phosphorylation	1
Cisplatin	affects cotreatment, decreases expression	1
Formaldehyde	decreases expression	1
Methapyrilene	increases methylation	1
Ribonucleotides	affects binding	1
Rotenone	decreases expression	1
Selenium	decreases expression	1
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	decreases expression	1
Aflatoxin M1	decreases expression	1
Antirheumatic Agents	increases expression	1
Particulate Matter	decreases expression, increases abundance	1

Cellosaurus cell lines

4 cell lines: 4 cancer cell line

First 10 cell lines (id-ordered, not curated):

Cellosaurus	Name	Category	Sex
CVCL_1661	ZR-75-30	Cancer cell line	Female
CVCL_C7Z8	HAP1 ZMYM4 (-) 1	Cancer cell line	Male
CVCL_C7Z9	HAP1 ZMYM4 (-) 2	Cancer cell line	Male
CVCL_C7ZA	HAP1 ZMYM4 (-) 3	Cancer cell line	Male

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.